View full meeting coverage »

Eyetube Meeting Coverage:

American Glaucoma Society 2018



Your 25-second video preview has ended.

to continue watching, please Log In or Register:

Log in / Register

Early Manifest Glaucoma Trial

  Channels: Glaucoma | Posted 3/3/2018

Keith Barton, MD, FRCP, FRCS, overviews the Early Manifest Glaucoma Trial (EMGT), a study designed to evaluate the effects of treatment versus no treatment on early-stage glaucoma. Dr. Barton describes a few notable characteristics of the EMGT and its key findings.

Clinical Trials

3 / 13 Series: American Glaucoma Society 2018